(4R)-4-[(3S,8S,9S,10R,13R,14S,17R)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-1-[4-(pyridin-4-ylmethoxy)piperidin-1-yl]pentan-1-one

C35H52N2O3 — CID 169312087

IUPAC(4R)-4-[(3S,8S,9S,10R,13R,14S,17R)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-1-[4-(pyridin-4-ylmethoxy)piperidin-1-yl]pentan-1-one
SMILESC[C@H](CCC(=O)N1CCC(OCc2ccncc2)CC1)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
InChIInChI=1S/C35H52N2O3/c1-24(4-9-33(39)37-20-14-28(15-21-37)40-23-25-12-18-36-19-13-25)30-7-8-31-29-6-5-26-22-27(38)10-16-34(26,2)32(29)11-17-35(30,31)3/h5,12-13,18-19,24,27-32,38H,4,6-11,14-17,20-23H2,1-3H3/t24-,27+,29+,30-,31+,32+,34+,35-/m1/s1
InChIKeyQWSNOGOEEIWHOS-HQNYHPTBSA-N
MW548.81 g/mol
LogP6.95
Rot. Bonds7

About (4R)-4-[(3S,8S,9S,10R,13R,14S,17R)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-1-[4-(pyridin-4-ylmethoxy)piperidin-1-yl]pentan-1-one

(4R)-4-[(3S,8S,9S,10R,13R,14S,17R)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-1-[4-(pyridin-4-ylmethoxy)piperidin-1-yl]pentan-1-one (PubChem CID 169312087) has the molecular formula C35H52N2O3 and a molecular weight of 548.81 g/mol. Its IUPAC name is (4R)-4-[(3S,8S,9S,10R,13R,14S,17R)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-1-[4-(pyridin-4-ylmethoxy)piperidin-1-yl]pentan-1-one.

Molecular Properties

Compound Name(4R)-4-[(3S,8S,9S,10R,13R,14S,17R)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-1-[4-(pyridin-4-ylmethoxy)piperidin-1-yl]pentan-1-one
PubChem CID169312087
Molecular FormulaC35H52N2O3
Molecular Weight548.81 g/mol
Exact Mass548.40
IUPAC Name(4R)-4-[(3S,8S,9S,10R,13R,14S,17R)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-1-[4-(pyridin-4-ylmethoxy)piperidin-1-yl]pentan-1-one
SMILESC[C@H](CCC(=O)N1CCC(OCc2ccncc2)CC1)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
InChIInChI=1S/C35H52N2O3/c1-24(4-9-33(39)37-20-14-28(15-21-37)40-23-25-12-18-36-19-13-25)30-7-8-31-29-6-5-26-22-27(38)10-16-34(26,2)32(29)11-17-35(30,31)3/h5,12-13,18-19,24,27-32,38H,4,6-11,14-17,20-23H2,1-3H3/t24-,27+,29+,30-,31+,32+,34+,35-/m1/s1
InChIKeyQWSNOGOEEIWHOS-HQNYHPTBSA-N
XLogP6.95
TPSA62.66 Ų
H-Bond Donors1
H-Bond Acceptors4
Rotatable Bonds7
Heavy Atoms40
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500548.81
LogP ≤ 56.95
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze (4R)-4-[(3S,8S,9S,10R,13R,14S,17R)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-1-[4-(pyridin-4-ylmethoxy)piperidin-1-yl]pentan-1-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (4R)-4-[(3S,8S,9S,10R,13R,14S,17R)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-1-[4-(pyridin-4-ylmethoxy)piperidin-1-yl]pentan-1-one?
The IUPAC name of (4R)-4-[(3S,8S,9S,10R,13R,14S,17R)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-1-[4-(pyridin-4-ylmethoxy)piperidin-1-yl]pentan-1-one (CID 169312087) is (4R)-4-[(3S,8S,9S,10R,13R,14S,17R)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-1-[4-(pyridin-4-ylmethoxy)piperidin-1-yl]pentan-1-one.
What is the SMILES notation for (4R)-4-[(3S,8S,9S,10R,13R,14S,17R)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-1-[4-(pyridin-4-ylmethoxy)piperidin-1-yl]pentan-1-one?
The canonical SMILES for (4R)-4-[(3S,8S,9S,10R,13R,14S,17R)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-1-[4-(pyridin-4-ylmethoxy)piperidin-1-yl]pentan-1-one is C[C@H](CCC(=O)N1CCC(OCc2ccncc2)CC1)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C.
What is the InChIKey of (4R)-4-[(3S,8S,9S,10R,13R,14S,17R)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-1-[4-(pyridin-4-ylmethoxy)piperidin-1-yl]pentan-1-one?
The InChIKey is QWSNOGOEEIWHOS-HQNYHPTBSA-N. The full InChI is InChI=1S/C35H52N2O3/c1-24(4-9-33(39)37-20-14-28(15-21-37)40-23-25-12-18-36-19-13-25)30-7-8-31-29-6-5-26-22-27(38)10-16-34(26,2)32(29)11-17-35(30,31)3/h5,12-13,18-19,24,27-32,38H,4,6-11,14-17,20-23H2,1-3H3/t24-,27+,29+,30-,31+,32+,34+,35-/m1/s1.
What are the key properties of (4R)-4-[(3S,8S,9S,10R,13R,14S,17R)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-1-[4-(pyridin-4-ylmethoxy)piperidin-1-yl]pentan-1-one?
(4R)-4-[(3S,8S,9S,10R,13R,14S,17R)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-1-[4-(pyridin-4-ylmethoxy)piperidin-1-yl]pentan-1-one has a molecular weight of 548.81 g/mol, XLogP of 6.95, 7 rotatable bonds, 1 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for (4R)-4-[(3S,8S,9S,10R,13R,14S,17R)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-1-[4-(pyridin-4-ylmethoxy)piperidin-1-yl]pentan-1-one is sourced from PubChem (CID 169312087), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).